ophthalmic optics company

Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M

by | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
Essilor Names Innovator Finalists in ‘See Change Challenge’
by | Mar 21, 2017
The French ophthalmic optics company with U.S. headquarters in Dallas, is leading a challenge to improve access to vision care.